T. Kylmälä et al. / Tetrahedron Letters 51 (2010) 3613–3615
3615
equilibrium9 between 3a-E and 3a-Z, however, formation of 4a
was not observed after 12 h at room temperature (entry 14).
The substituted N-tosylhydrazones 3a–d were subjected to the
optimized conditions and the results are collected in Table 3. In all
entries the reaction was complete in 10 min and the pure indazoles
were isolated without chromatography.
In summary, we have developed a facile strategy for the prepa-
ration of Z-configured N-tosylhydrazones. These compounds can
be utilized efficiently as precursors for the copper-catalyzed syn-
thesis of 3-methylindazoles under mild conditions. We believe that
this easy access to Z-hydrazones will open new possibilities for
metal-catalyzed C–H activation protocols. Further investigations
to extend this strategy to other substituents at the 3-position are
currently in progress in our laboratory and the results will be pre-
sented in due course.
2. (a) Pabba, C.; Wang, H.-J.; Mulligan, S. R.; Chen, Z.-J.; Stark, T. M.; Gregg, B. T.
Tetrahedron Lett. 2005, 46, 7553–7557; (b) Lebedev, A. Y.; Khartulyari, A. S.;
Voskoboynikov, A. Z. J. Org. Chem. 2005, 70, 596–602; (c) Viña, D.; del Olmo, E.;
López-Pérez, J. L.; San Feliciano, A. Org. Lett. 2007, 9, 525–528; (d) Inamoto, K.;
Katsuno, M.; Yoshino, T.; Arai, Y.; Hiroya, K.; Sakamoto, T. Tetrahedron 2007, 63,
2695–2711; (e) Liu, R.; Zhu, Y.; Qin, L.; Ji, S. Synth. Commun. 2008, 38, 249–254;
(f) Suryakiran, N.; Prabhakar, P.; Venkateswarlu, Y. Chem. Lett. 2007, 36, 1370–
1371; (g) Cho, C. S.; Lim, D. K.; Heo, N. H.; Kim, T.-J.; Shim, S. C. Chem. Commun.
2004, 104–105.
3. Bamford, W. R.; Stevens, T. S. J. Chem. Soc. 1952, 4735–4740.
4. Bunnell, C. A.; Fuchs, P. L. J. Org. Chem. 1977, 42, 2614–2617.
5. Udd, S.; Jokela, R.; Franzén, R.; Tois, J. Tetrahedron Lett. 2010, 51, 1030–1033.
6. For the mechanism for the formation of Z-oximes, see: (a) Smith, J. H.; Kaiser, E.
T. J. Org. Chem. 1974, 39, 728–730; (b) Wimalasena, K.; Haines, D. C. J. Org. Chem.
1994, 59, 6472–6475.
7. (a) King, H. D.; Denhart, D. J.; Deskus, J. A.; Ditta, J. L.; Epperson, J. R.; Higgins, M.
A.; Kung, J. E.; Marcin, L. R.; Sloan, C. P.; Mattson, G. K.; Molski, T. F.; Krause, R.
G.; Bertekap, R. L.; Lodger, N. J., Jr.; Mattson, R. J.; Macor, J. E. Bioorg. Med. Chem.
Lett. 2007, 17, 5647–5651; (b) Dehmlow, H.; Aebi, J. D.; Jolidon, S.; Ji, Y.-H.;
Mark, E. M.; Himber, J.; Morand, O. H. J. Med. Chem. 2003, 46, 3354–3370; (c)
Shutske, G. M.; Allen, R. C.; Forsch, M. F.; Setescak, L. L.; Wilker, J. C. J. Med. Chem.
1983, 26, 1307–1311; (d) Henke, B. R.; Aquino, C. J.; Birkemo, L. S.; Croom, D. K.;
Dougherty, R. W.; Ervin, G. N.; Grizzle, M. K.; Hirst, G. C.; James, M. K.; Johnson,
M. F.; Queen, K. L.; Sherrill, R. G.; Sugg, E. E.; Suh, E. M.; Szewczyk, J. W.; Unwalla,
R. J.; Yingling, J.; Willson, T. M. J. Med. Chem. 1997, 40, 2706–2725; (e) Steffan, R.
J.; Matelan, E.; Ashwell, M. A.; Moore, W. J.; Solvibile, W. R.; Trybulski, E.;
Chadwick, C. C.; Chippari, S.; Kenney, T.; Eckert, A.; Borges-Marcucci, L.; Keith, J.
C.; Xu, Z.; Mosyak, L.; Harnish, D. C. J. Med. Chem. 2004, 47, 6435–6438.
8. Estimation was made by ACD/Labs extension for CS ChemDraw (v 8.0); Advanced
Acknowledgments
The Academy ofFinland, for financial support (110043), is grate-
fully acknowledged. We also thank Mr. Mikko Mäkelä for valuable
assistance with pKa estimations.
Supplementary data
Supplementary data (experimental procedures, characteriza-
tion data, and 1H and 13C NMR spectra for new compounds are
available) associated with this article can be found, in the online
N
N
NHTs
OH
Br
pKa~ 9.22
Br
pKa~ 11.20
References and notes
1. (a) Schmidt, A.; Beutler, A.; Snovydovych, B. Eur. J. Org. Chem. 2008, 4073–4095.
and references therein; (b) Counceller, C. M.; Eichman, C. C.; Wray, B. C.;
Stambuli, J. P. Org. Lett. 2007, 10, 1021–1023.
9. Carbayo, A.; Cuevas, J. V.; García-Herbosa, G. J. Organomet. Chem. 2002, 658, 15–
20.